Literature DB >> 9834724

Prostate cancer: 4. Screening.

F Meyer1, Y Fradet.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9834724      PMCID: PMC1229744     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  13 in total

1.  Prospective evaluation plan for randomised trials of prostate cancer screening. The International Prostate Cancer Screening Trial Evaluation Group.

Authors:  A Auvinen; J B Rietbergen; L J Denis; F H Schröder; P C Prorok
Journal:  J Med Screen       Date:  1996       Impact factor: 2.136

2.  The European Screening Study for Prostate Cancer.

Authors:  F H Schröder
Journal:  Can J Oncol       Date:  1994-11

3.  Quebec prostate cancer mortality dropped in 1996.

Authors:  F Meyer; L Moore; I Bairati; Y Fradet
Journal:  Cancer Prev Control       Date:  1998-08

4.  Prognostic factors for clinically localized prostate carcinoma: analysis of 938 patients irradiated in the prostate specific antigen era.

Authors:  G K Zagars; A Pollack; A C von Eschenbach
Journal:  Cancer       Date:  1997-04-01       Impact factor: 6.860

5.  Cancer incidence and mortality, 1973-1995: a report card for the U.S.

Authors:  P A Wingo; L A Ries; H M Rosenberg; D S Miller; B K Edwards
Journal:  Cancer       Date:  1998-03-15       Impact factor: 6.860

6.  Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening.

Authors:  W J Catalona; D S Smith; T L Ratliff; J W Basler
Journal:  JAMA       Date:  1993-08-25       Impact factor: 56.272

Review 7.  Detection of latent prostate cancer from routine screening: comparison with breast cancer screening.

Authors:  R M Benoit; M J Naslund
Journal:  Urology       Date:  1995-10       Impact factor: 2.649

8.  Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.

Authors:  A B Miller; C J Baines; T To; C Wall
Journal:  CMAJ       Date:  1992-11-15       Impact factor: 8.262

9.  Population-based study of long-term survival in patients with clinically localised prostate cancer.

Authors:  G L Lu-Yao; S L Yao
Journal:  Lancet       Date:  1997-03-29       Impact factor: 79.321

10.  American Cancer Society--National Prostate Cancer Detection Project. Results from multiple examinations using transrectal ultrasound, digital rectal examination, and prostate specific antigen.

Authors:  C Mettlin; G P Murphy; P Ray; A Shanberg; A Toi; A Chesley; R Babaian; R Badalament; R A Kane; F Lee
Journal:  Cancer       Date:  1993-02-01       Impact factor: 6.860

View more
  11 in total

1.  Prostate cancer from a patient's perspective.

Authors:  D Grundy
Journal:  CMAJ       Date:  1999-06-29       Impact factor: 8.262

2.  Understanding obesity.

Authors:  J D Douketis
Journal:  CMAJ       Date:  1999-06-29       Impact factor: 8.262

3.  The more the better?

Authors:  M Simunovic; T To; B Langer
Journal:  CMAJ       Date:  1999-06-29       Impact factor: 8.262

4.  Understanding obesity.

Authors:  T M Stein
Journal:  CMAJ       Date:  1999-06-29       Impact factor: 8.262

5.  PSA screening: a view from the front lines. North York General-Branson Practice-Based Small Group.

Authors:  M Greiver; N Rosen
Journal:  CMAJ       Date:  2000-03-21       Impact factor: 8.262

Review 6.  Prostate cancer. What men want from their family physicians.

Authors:  R Gray
Journal:  Can Fam Physician       Date:  2000-09       Impact factor: 3.275

Review 7.  Prostate cancer: 13. Whose prostate is it anyway? The view from the other side of the examining table.

Authors:  R E Gray; A Philbrook
Journal:  CMAJ       Date:  1999-03-23       Impact factor: 8.262

8.  Radical prostatectomy as treatment for prostate cancer.

Authors:  Michael A S Jewett; Neil Fleshner; Lawrence H Klotz; Robert K Nam; John Trachtenberg
Journal:  CMAJ       Date:  2003-01-07       Impact factor: 8.262

9.  How did the PSA system arise?

Authors:  Stewart Justman
Journal:  J R Soc Med       Date:  2010-07-07       Impact factor: 5.344

10.  Should Canadians be offered systematic prostate cancer screening? No.

Authors:  Michel Labrecque; France Légaré; Michel Cauchon
Journal:  Can Fam Physician       Date:  2007-06       Impact factor: 3.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.